Amid a congressional standoff over COVID funding, the federal government will delay buying “hundreds of thousands” of monoclonal antibody treatments and instead cut state allocations of the drug by 30% starting next week to stretch supplies, senior Biden administration officials said Tuesday. This is the first time administration officials are threatening pain in the form of cutbacks to the states if Congress doesn’t approve new COVID-19 response funding.
